Semaphore Solutions Announces an Additional Investment from Cypress Ridge Capital to Accelerate Growth of Labbit, the only Agentic AI Lab Platform for Clinical, Molecular Diagnostics, Biopharmaceutical, and Manufacturing QC Laboratories
Semaphore Solutions, a leader in laboratory informatics solutions, announces a new investment from Cypress Ridge Capital (“CRC”) to further accelerate the growth of its flagship platform, Labbit. The growth equity investment builds on Cypress Ridge’s initial investment in February 2023 and supports the continued organic and inorganic expansion of Labbit as the only agentic AI platform for laboratories in Clinical, Molecular Diagnostics (MDx), Biopharmaceutical, and Manufacturing QC sectors.
